July 3, 2000 | Victor Appay, Douglas F. Nixon, Sean M. Donahoe, Geraldine M.A. Gillespie, Tao Dong, Abigail King, Graham S. Ogg, Hans M.L. Spiegel, Christopher Conlon, Celsa A. Spina, Diane V. Havlir, Douglas D. Richman, Anele Waters, Philippa Easterbrook, Andrew J. McMichael, Sarah L. Rowland-Jones
The article discusses the functional characteristics of HIV-specific CD8+ T cells, highlighting their ability to produce antiviral cytokines but their impaired cytolytic function. Using a combination of tetramer staining and intracellular cytokine staining, the study assessed the functional heterogeneity of antigen-specific CD8+ T cells in HIV-infected individuals. It found that most HIV-specific CD8+ T cells produce antiviral cytokines like IFN-γ and MIP-1β in response to antigen, but they express significantly lower levels of perforin compared to CMV-specific CD8+ T cells. This reduced perforin expression is linked with persistent CD27 expression, indicating impaired maturation. As a result, HIV-specific CD8+ T cells show lower ex vivo killing activity compared to CMV-specific cells from the same donor. The study also found that HIV-specific CD8+ T cells are not affected by HAART treatment in terms of cytokine secretion. The differences in maturation markers between HIV-specific and CMV-specific CD8+ T cells suggest that HIV-specific cells are at an earlier stage of maturation. These findings indicate that while HIV-specific CD8+ T cells can produce antiviral cytokines, their impaired cytolytic function may limit their ability to control HIV replication. The study provides insights into the functional characteristics of HIV-specific CD8+ T cells and highlights the importance of understanding their role in viral control.The article discusses the functional characteristics of HIV-specific CD8+ T cells, highlighting their ability to produce antiviral cytokines but their impaired cytolytic function. Using a combination of tetramer staining and intracellular cytokine staining, the study assessed the functional heterogeneity of antigen-specific CD8+ T cells in HIV-infected individuals. It found that most HIV-specific CD8+ T cells produce antiviral cytokines like IFN-γ and MIP-1β in response to antigen, but they express significantly lower levels of perforin compared to CMV-specific CD8+ T cells. This reduced perforin expression is linked with persistent CD27 expression, indicating impaired maturation. As a result, HIV-specific CD8+ T cells show lower ex vivo killing activity compared to CMV-specific cells from the same donor. The study also found that HIV-specific CD8+ T cells are not affected by HAART treatment in terms of cytokine secretion. The differences in maturation markers between HIV-specific and CMV-specific CD8+ T cells suggest that HIV-specific cells are at an earlier stage of maturation. These findings indicate that while HIV-specific CD8+ T cells can produce antiviral cytokines, their impaired cytolytic function may limit their ability to control HIV replication. The study provides insights into the functional characteristics of HIV-specific CD8+ T cells and highlights the importance of understanding their role in viral control.